Records containing: Systemic Lupus Erthematosus
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-15Patient-Centered Assessment of Symptoms and Outcomes
-
CLINICAL_TRIALS study record update · 2026-03-10A Phase Ib/IIa Clinical Trial Evaluating the Safety, Tolerability, and Efficacy of GR1803 Injection in Subjects With Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2026-03-10The Immunogenicity and Safety of COVID-19 and Influenza Vaccine Co-administration and Interval in Immunocompromised Hosts
-
CLINICAL_TRIALS study record update · 2025-12-02Water-based Liuzijue Exercise on Childhood-onset Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-12-01An Exploratory Clinical Study on the Safety and Efficacy of CD19/BCMA Chimeric Antigen Receptor NK Cells in the Treatment of B Cell-related Autoimmune Diseases in Children
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-09-23Mass Spectrometry-based Immune Profiling in Peripheral Blood of Autoimmune Diseases
-
CLINICAL_TRIALS study record update · 2025-09-11A Phase I, Open-Label Study to Evaluate the Safety and Tolerability of Subcutaneous Administration of Umbilical Cord Derived - Mesenchymal Stromal Cell Therapy in Addition to Standard of Care as A Treatment For Active Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-08-22An Open-label, Non-comparative Clinical Study of the Safety, Pharmacokinetics, Immunogenicity BCD-256 and Divozilimab in Monotherapy and Combination Therapy With Single and Multiple Intravenous Administration to Subjects With Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-08-20A Single-center Clinical Study Evaluating the Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells（QH103） in Refractory Autoimmune Diseases
-
CLINICAL_TRIALS study record update · 2025-08-08Cardiovascular Risk in Children With Chronic Conditions Study
-
CLINICAL_TRIALS study record update · 2025-02-25Evaluation of Serum Fibroblast Growth Factor 21 Levels in Patients With Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-02-12Safety and Efficacy of Universal CAR-T Cells (UWD-CD19) Combined with Immunosuppressants in the Treatment of Refractory Autoimmune Diseases
-
CLINICAL_TRIALS study record update · 2025-01-03Renal Resistive Index as an Indicator of Lupus Nephritis Severity and Systemic Lupus Activity
-
CLINICAL_TRIALS study record update · 2024-12-17Fatigue in Systemic Lupus Erythematosus: Which Variables Play a Role?
-
CLINICAL_TRIALS study record update · 2024-10-15Rare Autoimmune Self-management Programme Development
-
CLINICAL_TRIALS study record update · 2024-09-19Evaluation of Bone Mineral Density in Patients With Childhood-onset Systemic Lupus Erythematous, in Relation to Disease Clinical Criteria
-
CLINICAL_TRIALS study record update · 2022-04-20A Phase 1b, Randomized, Double-Blind, Placebo Controlled Study With an Open Label Extension to Evaluate the Safety and Tolerability of Omalizumab, A Humanized IgG1 Monoclonal Antibody in Patients With Lupus (STOP LUPUS)